Proposal for the interaction of non-conventional partial agonists and catecholamines with the 'putative β4-adrenoceptor' in mammalian heart

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 9-10, 1997, Pages 647-656

  Molenaar, Peter ^a   Sarsero, Doreen ^a   Kaumann, Alberto J ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

( ) 3H CGP 12177A; Atypical adrenoceptors; cAMP dependent pathway; Catecholamines; CGP 12177A; Human atrium; Human heart; Human ventricle; Non conventional partial agonists; Putative 4 adrenoceptor; Rat atrium; RO363

Indexed keywords

1 (3,4 DIHYDROXYPHENOXY) 3 (3,4 DIMETHOXYPHENETHYLAMINO) 2 PROPANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [(2 HYDROXY 2 PHENYLETHYL)AMINO]ETHOXY]PHENYLACETIC ACID; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ADENYLATE CYCLASE; ADRENALIN; ALPRENOLOL; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUPRANOLOL; CARAZOLOL; CATECHOLAMINE DERIVATIVE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ISOPRENALINE; NORADRENALIN; PARTIAL AGONIST; PINDOLOL; PINDOLOL DERIVATIVE; RECEPTOR SUBTYPE; [[7 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO] 5,6,7,8 TETRAHYDRO 2 NAPHTHYL]OXY]ACETIC ACID ETHYL ESTER;

CHRONOTROPISM; DRUG RECEPTOR BINDING; HEART; HEART ATRIUM MUSCLE; HEART VENTRICLE; HUMAN; ISOMERISM; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SINUS NODE;

EID: 0030930065     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb02107.x     Document Type: Review

References (82)

1. Carlsson E, Äblad B, Brandstrom A, Carlsson B. Differentiated blockade of the chronotropic effects of various adrenergic stimuli in the cat heart. Life Sci. 1972; 11: 953-8.
2. Kaumann AJ, Morris TH, Bojar H. Heart β-receptors: On the functional role of heterogeneous binding sites. J. Receptor Res. 1983; 3: 61-70.
3. Molenaar P, McPherson GA, Malta E, Raper C. Comparison of β-adrenoceptor populations in cat and guinea-pig left atria. J. Pharm. Pharmacol. 1985; 37: 257-60.
4. 2-adrenoceptor-mediated positive inotropic effect possibly unrelated to cyclic AMP. Naunyn Schmiedebergs Arch. Pharmacol. 1991; 344: 56-69.
5. 2-adrenoceptors activated by (-)-adrenaline in rat sinoatrial node. Naunyn Schmiedebergs Arch. Pharmacol. 1986; 333: 73-6.
6. 2-adrenoceptors. J. Auton. Pharmacol. 1995; 15: 239-55.
7. 2-adrenoceptors but does not transregulate muscarinic cholinoceptors in rat heart. Naunyn Schmiedebergs Arch. Pharmacol. 1996; 353: 213-25.
8. Kaumann AJ, Birnbaumer L, Wittmann R. Heart β-adrenoceptors. In: Birnbaumer L, O'Malley BWO (eds). Hormone Receptors. Academic Press, New York. 1978; 133-77.
9. Molenaar P, Summers RJ. Characterization of Beta-1 and Beta-2 adrenoceptors in guinea pig atrium: Functional and receptor binding studies. J. Pharmacol. Exp. Ther. 1987; 241: 1041-7.
10. Molenaar P, Canale E, Summers RJ. Autoradiographic localization of Beta-1 and Beta-2 adrenoceptors in guinea pig atrium and regions of the conducting system. J. Pharmacol. Exp. Ther. 1987; 241: 1048-64.
11. 2-adrenoceptors in guinea-pig atrioventricular conducting system. J. Mol. Cell. Cardiol. 1990; 22: 483-95.
12. Molenaar P, Smolich JJ, Russell FD, McMartin LR, Summers RJ. Differential regulation of Beta-1 and Beta-2 adrenoceptors in guinea pig atrioventricular conducting system after chronic (-)-isoproterenol infusion. J. Pharmacol. Exp. Ther. 1990; 55: 393-400.
13. 4 receptor population in piglet right atrium: Functional relevance. Br. J. Pharmacol. 1995; 115: 933-6.
14. Molenaar P, Jones CR, McMartin LR, Summers RJ. Autoradiographic localization and densitometric analysis of Beta-1 and Beta-2 adrenoceptors in the canine left anterior descending coronary artery. J. Pharmacol. Exp. Ther. 1988; 246: 384-93.
15. 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylyl cyclase stimulation by (-)-noradrenaline and (-)-adrenaline. Naunyn Schmiedebergs Arch. Pharmacol. 1985; 331: 60-70.
16. Kaumann AJ, Lobnig BM. Mode of action of (-)-pindolol on feline and human myocardium. Br. J. Pharmacol. 1986; 89: 207-18.
17. Buxton BF, Jones CR, Molenaar P, Summers RJ. Characterization and autoradiographic localization of β-adrenoceptor subtypes in human cardiac tissues. Br. J. Pharmacol. 1987; 92: 299-310.
18. 2-Adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium. Naunyn Schmiedehergs Arch. Pharmacol. 1987; 335: 403-11.
19. 2-adrenoceptors of human atrium and ventricle to the effects of noradrenaline and adrenaline as assessed with (-)-atenolol. Br. J. Pharmacol 1988; 95: 55-66.
20. Jones CR, Molenaar P, Summers RJ. New views of human cardiac β-adrenoceptors. J. Mol. Cell. Cardiol. 1989; 21: 519-35.
21. 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur. Heart J. 1989; 10 (Suppl. B): 29-37.
22. 2-adrenoceptors. Pharmacol. Commun. 1995; 6: 215-22.
23. 2-adrenoceptors in human atrial myocardium. Circ. Res. 1990; 66: 1610-23.
24. 2-adrenoceptors in the human atrioventricular conducting system: A comparison of patients with idiopathic dilated cardiomyopathy and ischemic heart disease. J. Mol. Cell. Cardiol. 1994; 26: 313-23.
25. 3-adrenoceptors. Br. J. Pharmacol. 1997; 120: 165-76.
26. 3-adrenoceptor in the human heart. J. Clin. Invest. 1996; 98: 556-62.
27. Kaumann AJ. Adrenergic receptors in heart muscle. Two different mechanisms of β blockers as partial agonists. International Union of Biochemistry. Symposium 52. Acta Physiol. Latamer 1973; 72: 63-82.
28. Kaumann AJ. Is there a third heart β-adrenoceptor? Trends Pharmacol. Sci. 1989; 10: 316-20.
29. Kaumann AJ. (-)-CGP 12177-induced increase of human atrial contraction through a putative third β-adrenoceptor. Br. J. Pharmacol. 1996; 117: 93-8.
30. 3-adrenoceptor in the rat. Br. J. Pharmacol. 1996; 118: 2085-98.
31. 3-adrenoceptors. Br. J. Pharmacol. 1996; 117: 943-9.
32. Man'Int Veld AJ, Schalekamp MADH. Pindolol acts as a beta-adrenoceptor agonist in orthostatic hypotension: Therapeutic implications. BMJ 1981; 282: 929-31.
33. Sarsero D, Molenaar P, Kaumann AJ. The human cardiac atypical β-adrenoceptor stimulates a cyclic AMP-dependent pathway. J. Mol. Cell. Cardiol. 1996; 28: A274.
34. 4-adrenoceptor' causes positive inotropic effects and hastens relaxation in human atrium and ventricle through a cAMP dependent pathway. Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol. 1996; 3: 38 (Abstract).
35. 3-adrenoceptors and is coupled to a cyclic AMP-dependent pathway in rat and human myocardium. Br. J. Pharmacol. 1997; 120: 102P.
36. Kaumann AJ, Molenaar P. Some aspects of human cardiac function modulated through 4 β-adrenoceptor populations. Naunyn Schmiedebergs Arch. Pharmacol. 1997; 355: 667-81.
37. Walter M, Lemoine H, Kaumann AJ. Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of guinea pig. Role of β-adrenoceptor subtypes in the dissociation between blockade and stimulation. Naunyn Schmiedebergs Arch. Pharmacol. 1984; 327: 159-75.
38. Lemoine H, Kaumann AJ. A model for the interaction of competitive antagonists with two receptor-subtypes characterized by a Schild-plot with apparent slope unity. Agonist-dependent enantiomeric affinity ratios for bupranolol in tracheae but not in right atria of guinea pigs. Naunyn Schmiedebergs Arch. Pharmacol. 1983; 322: 111-20.
39. 3-selective adrenoceptor antagonist, SR 59230A. Br. J. Pharmacol. 1996; 117: 1374-6.
40. Hoey A, Jackson C, Pegg G, Sillence M. Atypical response of rat ileum to pindolol, cyanopindolol and iodocyanopindolol. Br. J. Pharmacol. 1996; 117: 712-16.
41. 3-adrenoceptor in rat ileum. Br. J. Pharmacol. 1996; 119: 564-8.
42. 3-adrenergic receptor. Science 1989; 245: 1118-21.
43. 3-adrenergic receptor. Mol. Pharmacol. 1991; 49: 895-9.
44. 3-adrenergic receptor gene. Mol. Pharmacol. 1993; 44: 264-70.
45. 3-adrenergic receptors: Differential agonist activation of recombinant receptors in Chinese hamster ovary cells. Mol. Pharmacol. 1992; 42: 634-7.
46. 3-adrenoceptor. Br. J. Pharmacol. 1994; 112: 911-19.
47. 3-adrenoceptor agonist. Eur. J. Pharmacol. 1995; 291: 359-66.
48. 3-adrenergic receptor. J. Biol. Chem. 1991; 266: 20 329-36.
49. Wilson S, Changers JK, Park JE et al. Agonist potency at the cloned human Beta-3 depends on receptor expression level and nature of assay. J. Pharmacol. Exp. Ther. 1996; 279: 214-21.
50. 3-adrenergic receptor expression in 3T3-F442A adipocytes: A mechanism for repressing the cAMP signaling pathway. Proc. Natl Acad. Sci. USA 1994; 91: 5677-81.
51. Granneman JG, Whitty C. CGP 12177A modulates brown fat adenylate cyclase activity by interacting with two distinct receptor sites. J. Pharmacol. Exp. Ther. 1991; 256: 421-5.
52. 3-adrenergic receptors to brown fat adenylyl cyclase. J. Pharmacol. Exp. Ther. 1992; 261: 633-7.
53. 3-adrenoceptor in man. Br. J. Pharmacol. 1993; 110: 929-36.
54. 3-adrenoceptors in obesity. J. Clin. Invest. 1995; 95: 1109-16.
55. 3 and atypical β-adrenoceptors. Med. Res. Rev. 1993; 13: 663-729.
56. 3) β-adrenoceptors. Pharmacol. Commun. 1995; 6: 253-8.
57. 3-adrenergic receptor gene. J. Biol. Chem. 1995; 270: 29483-92.
58. Kaumann AJ, Lynham JA. (-)-CGP 12177A stimulates cyclic AMP-dependent protein kinase in rat atria through an atypical β-adrenoceptor. Br. J. Pharmacol. 1997; 120: 1187-9.
59. 2-Adrenoceptor-mediated relaxation and phosphorylation of phospholamban in human ventricle. Aust. N.Z. J. Med. 1997; 27: 108.
60. 2-Adrenoceptor activation by zinterol causes protein phosphorylation, contractile effects and relaxant effects through a cAMP pathway in human atrium. Mol. Cell. Biochem. 1996; 163/164: 113-23.
61. 2-Adrenoceptor-mediated relaxation and phosphorylation of phospholamban and troponin I in human ventricular trabeculae. In: Myocardial Functions: Pathophysiological, Methodological and Clinical Aspects. Proceedings of the III International Conference, 23-5 October 1996, Padova.
62. 2-adrenoceptors in human atrium. Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol. 1996; 3: 39 (Abstract).
63. Freestone N, Kaumann AJ. Activation of an atypical β-adrenoceptor increases calcium and can elicit arrhythmias in rat atrial cardiomyocytes. Pharmacologist 1997; 39: 74 (Abstract 292).
64. Kaumann AJ, Freestone N. Atypical β-adrenoceptor activation by (-)-CGP 12177 increases cytosolic calcium in rat ventricular myocytes. Pharmacologist 1997; 39: 74 (Abstract 293).
65. 2-adrenoceptors mediate catecholamine-evoked arrhythmias in isolated human right atrium. Naunyn Schmiedebergs Arch. Pharmacol. 1993; 348: 536-40.
66. 4 receptors in human atrium: Facilitation by chronic β-adrenoceptor blockade. Naunyn Schmiedebergs Arch. Pharmacol. 1994; 349: 331-6.
67. 2 receptor systems in human atrium: Role of cyclic nucleotides. Naunyn Schmiedebergs Arch. Pharmacol. 1996; 353: 661-70.
68. 3-adrenoceptors in man. Q. J. Med. 1993; 86: 255-61.
69. 3H]-CGP 12177A labels the atypical β-adrenoceptor (βAR) in rat atrium. Pharmacologist 1997; 39: 39 (Abstract 104).
70. 3H]-CGP 12177A for resolving subtype-selectivity of competitive ligands. Naunyn Schmiedebergs Arch. Pharmacol. 1987; 336: 519-25.
71. 2-adrenoceptor sites. Br. J. Pharmacol. 1984; 82: 897-904.
72. McPherson GA, Molenaar P, Malta E. The affinity and efficacy of naturally occurring catecholamines at β-adrenoceptor subtypes. J. Pharm. Pharmacol. 1985; 37: 499-501.
73. Germack R, Starzec AB, Vassy R, Perret GY. β-Adrenoceptor subtype expression and function in rat white adipocytes. Br. J. Pharmacol. 1997; 120: 201-10.
74. 3-adrenoceptors in intact brown adipocytes of the rat. Br. J. Pharmacol. 1995; 114: 275-82.
75. Muzzin P, Revelli J-P, Kuhne F et al. An adipose tissue-specific β-adrenergic receptor. Molecular cloning and down-regulation in obesity. J. Biol. Chem. 1991; 266: 24053-8.
76. Bearer CF, Knapp RD, Kaumann AJ, Schwartz TL, Birnbaumer L. lodohydroxybenzylpindolol: Preparation, purification, localization of its iodine in the indole ring, and characterization as a partial agonist. Mol. Pharmacol. 1980; 17: 328-38.
77. Kaumann AJ, Blinks JR. β-Adrenoceptor blocking agents as partial agonists in isolated heart muscle: Dissociation of stimulation and blockade. Naunyn Schmiedehergs Arch. Pharmacol. 1980; 311: 237-48.
78. Kaumann AJ. Cardiac β-adrenoceptors. Experimental viewpoints. Z. Kardiol. 1983; 72: 63-82.
79. Kaumann AJ, Morris TH, Birnbaumer L. A comparison of the influence of N-tert butyl substituents on the affinity of ligands for sinoatrial β-adrenoceptors in rat atria and β-adrenoceptors coupled to the adenylyl cyclase in kitten ventricle. Naunyn Schmiedebergs Arch. Pharmacol. 1979; 307: 1-8.
80. 2-Adrenoceptor binding sites in circular and longitudinal myometrial layers of the virgin guinea-pig: The influence of ovarian steroids. J. Auton. Pharmacol. 1986; 6: 207-13.
81. Handberg GM, Davis EA, Hall S, Molenaar P, Summers RJ, Pennefather JN. β-Adrenoceptors in circular and longitudinal myometrial membranes and in lung membranes from dioestrous and post-partum guinea-pigs. Clin. Exp. Pharmacol. Physiol. 1988; 15: 681-93.
82. 2-adrenoceptors. Eur. J. Pharmacol. 1986; 130: 137-40.